AU6985696A - Process to obtain oestrogens from mare's urine - Google Patents

Process to obtain oestrogens from mare's urine

Info

Publication number
AU6985696A
AU6985696A AU69856/96A AU6985696A AU6985696A AU 6985696 A AU6985696 A AU 6985696A AU 69856/96 A AU69856/96 A AU 69856/96A AU 6985696 A AU6985696 A AU 6985696A AU 6985696 A AU6985696 A AU 6985696A
Authority
AU
Australia
Prior art keywords
urine
gel
oestrogens
water
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU69856/96A
Other versions
AU722084B2 (en
Inventor
Ivan Ban
Friedrich Borchers
Henning Heinemann
Heinz-Helmer Rasche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Abbott Products GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products GmbH filed Critical Abbott Products GmbH
Publication of AU6985696A publication Critical patent/AU6985696A/en
Assigned to SOLVAY PHARMACEUTICALS GMBH reassignment SOLVAY PHARMACEUTICALS GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: SOLVAY DEUTSCHLAND GMBH
Application granted granted Critical
Publication of AU722084B2 publication Critical patent/AU722084B2/en
Assigned to ABBOTT PRODUCTS GMBH reassignment ABBOTT PRODUCTS GMBH Request to Amend Deed and Register Assignors: SOLVAY PHARMACEUTICALS GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Organic Insulating Materials (AREA)
  • Silicon Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

Recovery of a phenolics-depleted natural mixture of conjugated oestrogens from the urine of pregnant mares comprises (a) providing a liquid urine (which comprises a urine freed from mucous and solids, a concentrate of the latter or a urine retentate obtained by membrane filtration) and treating it with a water-soluble base to give a pH of at least 12 and subsequently treating with aqueous acid to adjust the pH to 5-8.5; (b) contacting the urine with a hydrophobised silica gel to adsorb the conjugated oestrogens and separating the gel from the mixture; (c) washing the gel with an aqueous buffer adjusted to pH 5-7; and (d) eluting the oestrogens from the gel using a mixture of water and a water-miscible solvent selected from ethers, lower alcohols and lower aliphatic ketones, and optionally concentrating the eluate;
AU69856/96A 1996-08-30 1996-08-30 Process to obtain oestrogens from mare's urine Ceased AU722084B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/003819 WO1998008525A1 (en) 1996-08-30 1996-08-30 Process to obtain oestrogens from mare's urine

Publications (2)

Publication Number Publication Date
AU6985696A true AU6985696A (en) 1998-03-19
AU722084B2 AU722084B2 (en) 2000-07-20

Family

ID=8166299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69856/96A Ceased AU722084B2 (en) 1996-08-30 1996-08-30 Process to obtain oestrogens from mare's urine

Country Status (17)

Country Link
EP (1) EP0927040B1 (en)
JP (1) JP4125788B2 (en)
AT (1) ATE264110T1 (en)
AU (1) AU722084B2 (en)
CA (1) CA2263904C (en)
CZ (1) CZ298762B6 (en)
DE (3) DE19681616D2 (en)
DK (1) DK0927040T3 (en)
ES (1) ES2219697T3 (en)
HK (1) HK1023063A1 (en)
HU (1) HU228765B1 (en)
IL (1) IL128671A (en)
NO (1) NO318378B1 (en)
PL (1) PL185920B1 (en)
PT (1) PT927040E (en)
SK (1) SK281367B6 (en)
WO (1) WO1998008525A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10037389A1 (en) 2000-08-01 2002-02-14 Solvay Pharm Gmbh Method and device for the enrichment and stabilization of conjugated estrogens from mare's urine
DE10159161A1 (en) * 2001-12-01 2003-06-18 Solvay Pharm Gmbh Process for obtaining estrogens from mare's urine
TWI332400B (en) 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
TWI252111B (en) 2001-12-14 2006-04-01 Solvay Pharm Gmbh Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
US20040072814A1 (en) 2002-10-11 2004-04-15 Solvay Pharmaceuticals Gmbh Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
AR041121A1 (en) * 2002-10-11 2005-05-04 Solvay Pharm Gmbh PROCEDURE FOR OBTAINING A NATURAL MIXTURE OF CONJUGATED STROGENS
CN1332973C (en) * 2003-03-06 2007-08-22 深圳市海达克实业有限公司 Extraction process of conjugated female hormone
CA2529009C (en) * 2003-07-17 2011-06-28 Solvay Pharmaceuticals Gmbh Method for obtaining a natural mixture of conjugated equine estrogens

Also Published As

Publication number Publication date
PT927040E (en) 2004-08-31
EP0927040A1 (en) 1999-07-07
DK0927040T3 (en) 2004-05-10
EP0927040B1 (en) 2004-04-14
DE59610986D1 (en) 2004-05-19
HK1023063A1 (en) 2000-09-01
CZ298762B6 (en) 2008-01-23
DE19681616D2 (en) 1999-09-30
HU228765B1 (en) 2013-05-28
CZ59999A3 (en) 1999-06-16
NO990953D0 (en) 1999-02-26
JP2000517309A (en) 2000-12-26
CA2263904A1 (en) 1998-03-05
CA2263904C (en) 2007-08-07
JP4125788B2 (en) 2008-07-30
WO1998008525A1 (en) 1998-03-05
PL185920B1 (en) 2003-08-29
SK24499A3 (en) 1999-10-08
IL128671A (en) 2001-03-19
HUP9903670A2 (en) 2000-03-28
ES2219697T3 (en) 2004-12-01
SK281367B6 (en) 2001-02-12
AU722084B2 (en) 2000-07-20
HUP9903670A3 (en) 2000-05-29
ATE264110T1 (en) 2004-04-15
NO318378B1 (en) 2005-03-14
DE19681616B4 (en) 2006-03-09
PL331885A1 (en) 1999-08-16
IL128671A0 (en) 2000-01-31
NO990953L (en) 1999-02-26

Similar Documents

Publication Publication Date Title
CA2254871A1 (en) Purification of biologically active peptides from milk
DE69633278D1 (en) DEVICE FOR DELIVERING A SELECTED MOLECULE INTO THE CIRCUIT SYSTEM
AU6985696A (en) Process to obtain oestrogens from mare's urine
NZ293707A (en) Mixed mode chromatographic resins for extraction of target compounds from an aqueous solution
EP0875563A3 (en) Improved methods for processing activated protein C
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
DE3262945D1 (en) Precipitating reagent for pre-b-lipoproteins, method of preparing the same and its use in the determination of hdl cholesterol
EP0816374A3 (en) A method of preparing a composition containing a high proportion of ganglioside
EP0752212A3 (en) Process for preparing fractionated soybean proteins and foods using the same
IE850608L (en) Process for the recovery of ceftazidime
IE821751L (en) Plasmapheresis
KR960009052B1 (en) Simultaneous preparation process of useful proteins from human urine
GR3007446T3 (en)
US4666843A (en) Method for the purification of calf rennet
EP0518448B1 (en) A method for isolating proteins from milk and a method for processing milk
EP0282018A3 (en) Process for isolating basal membrane proteins from human or animal tissues
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
DE3665579D1 (en) Purification and recovery of phenylalanine
FR2658517B2 (en) PREPARATION OF ACTIVATED PROTEIN C AND ACTIVATED PROTEIN C SOLUTION THUS OBTAINED.
RU99106510A (en) METHOD OF OBTAINING ESTROGENS FROM UCHE SABS
JPS5653105A (en) Preparation of water-insoluble tannin pharmaceutical preparation
SU983127A1 (en) Method of producing placenta lactogen
Belsak et al. Method for eluting adsorbed gold from carbon
DE3270177D1 (en) Process for purifying elastase
Bobrov et al. Neutron control of technological process of Pu precipitation; Nejtronnyj kontrol'tekhnologicheskogo protsessa osazhdeniya Pu

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: SOLVAY PHARMACEUTICALS GMBH

Free format text: THE FORMER OWNER WAS: SOLVAY DEUTSCHLAND GMBH

FGA Letters patent sealed or granted (standard patent)